All Stories

  1. Correction: Validity and psychometric characteristics of the Duruöz Hand Index (DHI) in patients with systemic sclerosis
  2. The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
  3. Validity and psychometric characteristics of the Duruöz Hand Index (DHI) with systemic sclerosis
  4. Effect of Vitamin D Deficiency on Fatigue in Systemic Sclerosis: A Cross-sectional Study
  5. Assessing Diagnosis, Demographics, and Medication Compliance in Elderly Patients with Rheumatic Disease
  6. Central Sensitization and Its Role in Persistent Pain Among Spondyloarthritis Patients on Biological Treatments
  7. Association of nutritional status indices with gastrointestinal symptoms in systemic sclerosis: a cross-sectional study
  8. The relationship between sacroiliac joint MRI scores and central sensitization in axial spondyloarthritis: A cross-sectional study
  9. Regional variations in psoriatic arthritis: Insights from a nationwide multicenter analysis in Türkiye
  10. Pelvic parameters as prognostic factors of radiographic progression in classical Ankylosing Spondylitis: A prospective follow-up data
  11. Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients
  12. Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients
  13. Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: a real-life evidence from biostar nationwide registry
  14. Validity and reliability of the Duruöz Hand Index in patients with psoriatic arthritis
  15. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry
  16. Diagnostic delay in psoriatic arthritis: insights from a nationwide multicenter study
  17. Familial Mediterranean fever: perspective on female fertility and disease course in pregnancy from a multicenter nationwide network
  18. Beyond expectations: disease duration and psychological burden in psoriatic arthritis
  19. AB1689 CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE TURKISH VERSION OF THE FLARE OA QUESTIONNAIRE FOR HIP AND KNEE OSTEOARTHRITIS
  20. POS0669 CROSS-SECTIONAL ANALYSIS OF CARDIOVASCULAR DISEASE AND RISK FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS: A REAL-LIFE EVIDENCE FROM BIOSTAR NATIONWIDE REGISTRY
  21. Clinical aspects and outcomes in osteoarthritis
  22. Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future
  23. AB0259 PREDICTIVE VALUE OF C-REACTIVE PROTEIN/ALBUMIN RATIO(CAR) FOR THE DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY
  24. AB0991 RADIOGRAPHIC EVALUATION OF FOOT SPURS IN SPONDYLOARTHRITIS
  25. AB1064 THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND CENTRAL SENSITIZATION IN SPONDYLOARTHROPATHY PATIENTS RECEIVING BIOLOGICAL TREATMENT
  26. AB1683 VALIDITY AND PSYCHOMETRIC CHARACTERISTICS OF THE DURUÖZ HAND INDEX IN PATIENTS WITH PSORIATIC ARTHRITIS
  27. AB0834 VALIDITY AND PSYCHOMETRIC CHARACTERISTICS OF THE DURUÖZ HAND INDEX IN TURKISH PATIENTS WITH SYSTEMIC SCLEROSIS
  28. Correlation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis
  29. The validity and reliability of the Turkish version of the Arthritis Impact Measurement Scale 2-Short Form (AIMS2-SF) for rheumatoid arthritis
  30. Association of pain and clinical factors on disability and quality of life in systemic sclerosis: A cross-sectional study from Turkish League Against Rheumatism Network
  31. Clinical and functional impact of central sensitization on patients with familial Mediterranean fever: a cross-sectional study
  32. Colchicine resistance: Associated factors and its effect on health‐related quality of life in patients with familial Mediterranean fever
  33. Spondyloarthritis in familial Mediterranean fever: a cohort study
  34. Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study
  35. Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis
  36. Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists
  37. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry
  38. Assessment of autonomic dysfunction with the COMPASS-31 and its relationship with disease activity and cardiovascular risks in patients with psoriatic arthritis
  39. The value of SPARCC sacroiliac MRI scoring in axial psoriatic arthritis and its association with other disease parameters
  40. Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis
  41. Validity and reliability of the Mini-Osteoarthritis Knee and Hip Quality of Life scale in Turkish population
  42. A standardized sonographic analysis of nails in psoriatic arthritis and healthy controls: Feasibility, reliability, diagnostic performance, and demographic and clinical associations
  43. Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR
  44. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment
  45. Reliability and validity of the Istanbul Low Back Pain Disability Index in lumbosacral radiculopathy
  46. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study
  47. Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: A multi-center study
  48. The impact of COVID-19 on familial Mediterranean fever: a nationwide study
  49. Familial Mediterranean fever: Health-related quality of life and associated variables in a national cohort
  50. PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis
  51. Fibromyalgia in patients with psoriatic arthritis: Relationship with enthesopathy, sleep, fatigue and quality of life
  52. The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis
  53. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry
  54. Clinical Characteristics, Disease Activity, Functional Status, and Quality of Life Results of Patients With Psoriatic Arthritis Using Biological and Conventional Synthetic Disease-Modifying Antirheumatic Drugs
  55. Development and validation of a quality of life scale in Familial Mediterranean Fever (FMFQoL)
  56. Large joint and lower extremity involvement have higher impact on disease outcomes in oligoarticular psoriatic arthritis
  57. The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network
  58. Validity, reliability, and factor structure of the Istanbul Low Back Pain Disability Index in axial spondyloarthritis
  59. The Turkish League Against Rheumatism Recommendations for the Management of Hand Osteoarthritis Under Guidance of the Current Literature and 2018 European League Against Rheumatism Recommendations
  60. The validity and reliability of the Turkish version of the Seattle Angina Questionnaire
  61. Neuropathic Pain: Unexplored and Significant Relationship With Psoriatic Arthritis and Functional Parameters
  62. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study
  63. Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort
  64. Cervical proprioceptive impairment in patients with rheumatoid arthritis
  65. Assessment of Hand Function
  66. Hand Function
  67. Pain and Hand Function
  68. Assessment of the validity and reliability of the Jenkins Sleep Scale in ankylosing spondylitis
  69. Static and Dynamic Balance Disorders in Patients With Rheumatoid Arthritis and Relationships With Lower Extremity Function and Deformities: A Prospective Controlled Study
  70. Turkish League Against Rheumatism (TLAR) Recommendations for the Pharmacological Management of Rheumatoid Arthritis: 2018 Update Under Guidance of Current Recommendations
  71. The evaluation of the static and dynamic balance disorders in patients with psoriatic arthritis
  72. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis
  73. The Validity and Reliability of Turkish Version of the Jenkins Sleep Evaluation Scale in Rheumatoid Arthritis
  74. Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions
  75. Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study
  76. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis
  77. AB0224 Cervical proprioceptive impairement in patients with rheumatoid arthritis
  78. SAT0329 Fibromyalgia in patient with psoriatic arthritis: relationship with enthesopathy, sleep, fatigue and quality of life
  79. FRI0652 The development and validation of familial mediterrenean fever quality of life scale (FMF-QOL)
  80. AB0911 The relationship between neuropathic pain and disease activity, sleep, fatigue, quality of life in patients with psoriatic arthritis
  81. Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis
  82. Validity and reliability of the Turkish version of the Jenkins Sleep Scale in psoriatic arthritis
  83. Fatigue in familial Mediterranean fever and its relations with other clinical parameters
  84. Validation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population
  85. Duruöz Hand Index: Is it valid and reliable in children with unilateral cerebral palsy?
  86. FRI0597 Fatigue in familial mediterranean fever (FMF) and its relations with other clinical parameters
  87. THU0692 The turkish validation and reliability of disease-specific, patient reported outcome measure in rheumatoid arthritis: TR AIMS2-SF
  88. The validity and reliability of Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) in a Turkish population
  89. The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients
  90. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages
  91. AB0250 Assessment of Balance and Its Relation with Clinical Parameters in Rheumatoid Arthritis Patients
  92. Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR
  93. Bilateral Camptodactyly in Twin Sisters
  94. Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures
  95. Characteristics of Patients With Rheumatoid Arthritis in Turkey: Results From the Turkish League Against Rheumatism Rheumatoid Arthritis Registry
  96. Hand function assessment in patients with juvenile idiopathic arthritis: usefulness of duruöz hand index
  97. Hand Function
  98. Assessment of Hand Functions
  99. Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis
  100. Polyarteritis Nodosa
  101. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire
  102. AB1391 The validity of duruÖz hand index (DHI) in geriatric population
  103. SAT0025 The Association Serum Interleukin 17 and Interleukin 23 Levels with Clinical and Radiological Parameters in Rheumatoid Arthritis Patients
  104. SAT0291 Evaluation of Sleep Quality in Psoriatic Arthritis Patients
  105. SAT0338 Adaptation and Validation of the Osteoarthritis Knee and Hip Quality of Life (Oakhqol) Questionnaire in Turkish Population.
  106. Development and validation of a functional disability index for chronic low back pain
  107. Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism
  108. Evaluation of metabolic syndrome in patients with chronic low back pain
  109. Quality of life and related variables in patients with ankylosing spondylitis
  110. Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP
  111. Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database
  112. Autoinflammatory conditions: when to suspect? How to treat?
  113. Treatment of Ankylosing Spondylitis with Biologic Agents
  114. Validation of Duruöz Hand Index for Diabetic Hand Dysfunction
  115. Relationship between enthesitis, clinical parameters and quality of life in spondyloarthritis
  116. Relation entre enthésite, paramètres cliniques et qualité de vie dans les spondylarthropathies
  117. Serum hyaluronic acid levels in patients with ankylosing spondylitis
  118. Assessment of fatigue in patients with ankylosing spondylitis
  119. Quality of life in patients with ankylosing spondylitis: a pilot study
  120. Radiologic features of lumbar spine in ochronosis in late stages
  121. The Frequency and Associated Factors of Low Back Pain Among a Younger Population in Turkey
  122. THU0205 Comparison of self-reporting measures of functional disability and clinical variables in rheumatoid arthritis in a turkish population